Glycophorin B inhibitors represent a class of chemical compounds specifically designed to target and modulate the activity of the glycophorin B protein. Glycophorins are integral membrane proteins present on the surface of red blood cells, playing crucial roles in various physiological processes, including cell adhesion and immune response. Glycophorin B, in particular, is involved in cell-cell interactions and is a key component in the formation of the glycophorin A-B complex, which participates in the maintenance of red blood cell structure and function. The development of glycophorin B inhibitors is rooted in the need to understand and manipulate these protein-protein interactions for potential applications in various biological studies.
Glycophorin B inhibitors typically comprise small organic molecules or peptides that exhibit high affinity and selectivity for binding to the glycophorin B protein. These inhibitors interfere with the normal function of glycophorin B, leading to altered cellular processes and responses. The structural design of these compounds often involves detailed insights into the three-dimensional arrangement of the glycophorin B protein, enabling the rational design of molecules that can specifically bind to its active sites. Researchers in this field aim to elucidate the precise mechanisms by which glycophorin B inhibitors interfere with protein function, providing valuable information for understanding the intricate molecular processes governing cell adhesion and related phenomena.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine is an antimalarial agent that can alter the glycosylation pattern in cells, which may affect the function or expression of glycoproteins like GPB. | ||||||
Benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside | 3554-93-6 | sc-203427 sc-203427A | 100 mg 1 g | $350.00 $3122.00 | 2 | |
This chemical can interfere with glycosylation, potentially altering the structure and function of glycoproteins including GPB. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin blocks N-linked glycosylation in cells, which could affect GPB as it is a sialoglycoprotein. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $180.00 $620.00 | 10 | |
An inhibitor of glycosidase enzymes, which could modify the glycosylation status of proteins like GPB. | ||||||
Swainsonine | 72741-87-8 | sc-201362 sc-201362C sc-201362A sc-201362D sc-201362B | 1 mg 2 mg 5 mg 10 mg 25 mg | $135.00 $246.00 $619.00 $799.00 $1796.00 | 6 | |
An inhibitor of glycoprocessing enzymes, which may alter GPB's glycosylation and, consequently, its function. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $72.00 $142.00 | ||
A glycosidase inhibitor that might alter glycoprotein processing, potentially impacting GPB's structure and function. | ||||||
Deoxymannojirimycin hydrochloride | 84444-90-6 | sc-201360 sc-201360A | 1 mg 5 mg | $93.00 $239.00 | 2 | |
Similar to Deoxynojirimycin, it inhibits glycosidase enzymes affecting glycoprotein processing. | ||||||
Kifunensine | 109944-15-2 | sc-201364 sc-201364A sc-201364B sc-201364C | 1 mg 5 mg 10 mg 100 mg | $132.00 $529.00 $1005.00 $6125.00 | 25 | |
A mannosidase inhibitor, it could influence the maturation of glycoproteins like GPB in the endoplasmic reticulum. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Disrupts Golgi apparatus function, which could indirectly impact the processing and trafficking of glycoproteins such as GPB. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
An ionophore that disrupts Golgi function, potentially affecting glycoprotein processing including that of GPB. |